Oncology & Cancer

Common mutation is culprit in acute leukemia relapse

Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research, published in Cancer Cell, could translate into improved patient care strategies ...

Oncology & Cancer

Tumor cell vaccination trial to promote anti-leukemia responses

Patients with advanced chronic lymphocytic leukemia (CLL) often receive donor transplants that effectively "reboot" their own immune defenses, which then attack and potentially cure the hard-to-treat disease. However, there ...

Oncology & Cancer

UK's "super mouse" yielding major discoveries in cancer research

It appears tiny and inconsequential enough, but the "super mouse"—created by researchers at the University of Kentucky Markey Cancer Center some six years ago—has spawned plenty of new research into preventing and/or ...

Oncology & Cancer

Mammograms reveal response to common cancer drug

Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, ...

page 5 from 8